Stock ABBVABBVIE INC.
Add to a list
To use this feature you must be a member
Log inSign up

News AbbVie Inc.

Equities

ABBV

US00287Y1091

Pharmaceuticals

Real-time Estimate Cboe BZX
Other stock markets
 12:53:15 2025-04-22 pm EDT 		5-day change 1st Jan Change
173.89 USD +2.19% Intraday chart for AbbVie Inc. -2.96% -2.20%
10:27am Trump Administration Mulls Cutting US Drug Prices to International Levels MT
10:22am Trump Mulls Cutting US Drug Prices to International Levels, Reuters Reports MT

Search
See the results
Trump Administration Mulls Cutting US Drug Prices to International Levels
10:27am
 MT
Trump Mulls Cutting US Drug Prices to International Levels, Reuters Reports
10:22am
 MT
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Cerevel Therapeutics Holdings, Inc.(ABBV) Shareholders
05:46am
 PR
Stock Futures Fall as Investors Await More Earnings, Digest Trump's Comments on Fed Chair Powell
Apr. 21
 MT
The Gross Law Firm Notifies Cerevel Therapeutics Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ABBV
Apr. 21
 PR
Shareholders that lost money on Cerevel Therapeutics Holdings, Inc.(ABBV) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Apr. 18
 PR
S&P 500 Falls on Week Led by Tech, Consumer Discretionary, Communication Services
Apr. 17
 MT
Global markets live: Nvidia, Amex, GSK, TSMC, Rio Tinto…
Apr. 17
Our Logo
ABBV LAWSUIT ALERT: The Gross Law Firm Notifies Cerevel Therapeutics Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Apr. 17
 PR
Ex-dividend day
Apr. 14
 FA
DNB Health Care down 10.90 percent in March - challenging month for global equity markets
Apr. 14
 FW
AbbVie Aesthetics Line Faces Potential Risk in Current Macro Environment, UBS Says
Apr. 11
 MT
Citigroup Adjusts Price Target on AbbVie to $210 From $215, Keeps Buy Rating
Apr. 11
 MT
Pharma Shares Reverse Losses After Tariff Pause
Apr. 09
 DJ
Tech stocks keep Wall St afloat amid raging US-China tariff war
Apr. 09
 RE
AbbVie Announces European Commission Approval of RINVOQ (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis
Apr. 09
 AQ
Pharma Stocks Slide Further After Trump Reiterates Tariff Threats on Drugs -- Update
Apr. 09
 DJ
Stocks in motion: Pharma and banks in the crosshairs
Apr. 09
Our Logo
Tech shares lift Wall Street amid escalating U.S.-China tariff war
Apr. 09
 RE
Morgan Stanley Adjusts Price Target on AbbVie to $241 From $239, Keeps Overweight Rating
Apr. 09
 MT
Wall St to open sharply lower as China raises more barriers on US goods
Apr. 09
 RE
Futures tumble as China hits back with more barriers on US goods
Apr. 09
 RE
Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines
Apr. 09
 DJ
Global pharma shares plunge as Trump doubles down on tariff threat
Apr. 09
 RE
AbbVie Gets Expanded Europe OK for Rinvoq in Giant Cell Arteritis
Apr. 08
 DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABBV Stock
  4. News AbbVie Inc.